Michael J. Rathbone, PhD is Founder and Managing Director of his own company, ULTI Pharmaceuticals, NZ. He is also an associate at University of Technology Sydney, Australia. He has taught at International Medical University, Kuala Lumpur, Malaysia and Griffith University, Australia and he was the Director of Research and General Manager InterAg, New Zealand, where he spearheaded the companies veterinary controlled drug delivery research and directed their national and global collaborative research activities. He is a Fellow of the Controlled Release Society, has served on the Board of Directors of the CRS and has received several prestigious awards for his contribution to the science and technology of controlled release. He has edited 8 books in the area of modified release drug delivery and 10 special theme issues of journals such as Advanced Drug Delivery Reviews (Elsevier) and Journal of Controlled Release (Elsevier).